Disclosure Statement Pursuant to the Pink Basic Disclosure Guidelines
Medical Care Technologies Inc. | |
2245 Texas Drive, Suite 300 | |
Sugar Land, TX 77479 | |
_______________________________ | |
281-566-2500 | |
https://medcaretechinc.com/ | |
info@medcaretechinc.com | |
SIC: 6719 | |
QuarterlyReport | |
For the Period Ending: 09/30/2021 | |
(the "Reporting Period") | |
As of 09/30/2021, the number of shares outstanding of our Common Stock was: | 2,959,575,220 |
As of 06/30/2021, the number of shares outstanding of our Common Stock was: | 2,959,575,220 |
As of 12/31/2020, the number of shares outstanding of our Common Stock was: | 2,959,575,220 |
Indicate by check mark whether the company is a shell company (as defined in Rule 405 of the Securities Act of 1933 and Rule 12b-2 of the Exchange Act of 1934):
Yes: ☒ No: ☐
Indicate by check mark whether the company's shell status has changed since the previous reporting period:
Yes: ☐ No: ☒
Indicate by check mark whether a Change in Control1 of the company has occurred over this reporting period:
Yes: ☐ | No: ☒ |
- Name and address(es) of the issuer and its predecessors (if any)
1 "Change in Control" shall mean any events resulting in:
(i) Any "person" (as such term is used in Sections 13(d) and 14(d) of the Exchange Act) becoming the "beneficial owner" (as defined in Rule 13d-3 of the Exchange Act), directly or indirectly, of securities of the Company representing fifty percent (50%) or more of the total voting power represented by the Company's then outstanding voting securities;
- The consummation of the sale or disposition by the Company of all or substantially all of the Company's assets;
- A change in the composition of the Board occurring within a two (2)-year period, as a result of which fewer than a majority of the directors are directors immediately prior to such change; or
- The consummation of a merger or consolidation of the Company with any other corporation, other than a merger or consolidation which would result in the voting securities of the Company outstanding immediately prior thereto continuing to represent (either by remaining outstanding or by being converted into voting securities of the surviving entity or its parent) at least fifty percent (50%) of the total voting power represented by the voting securities of the Company or such surviving entity or its parent outstanding immediately after such merger or consolidation.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 1 of 10 |
In answering this item, provide the current name of the issuer any names used by predecessor entities, along with the dates of the name changes.
The name of the issuer is Medical Care Technologies Inc.
The previous name of the issuer was AM Oil Resources & Technology Inc. until October 2009. The previous name of the issuer was Aventerra Explorations Inc. until December 2008.
The state of incorporation or registration of the issuer and of each of its predecessors (if any) during the past five years; Please also include the issuer's current standing in its state of incorporation (e.g. active, default, inactive):
The issuer was incorporated in the State of Nevada in February 2007 as Aventerra Exploration, Inc. The issuer amended its Articles of Incorporation to change its name to AM Oil Resources & Technology, Inc. in December 2008. The issuer merged with Medical Care Technologies, Inc. and changed its name to Medical Care Technologies, Inc. in October 2009.
The issuer is incorporated in the State of Nevada in good standing and "Active".
Describe any trading suspension orders issued by the SEC concerning the issuer or its predecessors since inception:
N/A
List any stock split, stock dividend, recapitalization, merger, acquisition, spin-off, or reorganization either currently anticipated or that occurred within the past 12 months:
On June 3, 2021, the Custodian designated one share of preferred stock as Special 2021 Series A Preferred Stock at par value of $0.00001. The Special 2021 Series A Preferred has 60% voting rights over all classes of stock and is convertible into 3,000,000,000 shares of the Company's common stock.
On June 3, 2021, the Custodian granted to itself, one share of preferred stock, Special 2021 Series A Preferred Stock at par value of $0.00001.
On June 14, 2021, in a private transaction, the Custodian entered into a Securities Purchase Agreement (the "SPA") with Krisa Management LLC, a Texas limited liability company, to sell the Special 2021 Series A Preferred. Upon closing of the SPA on June 14, 2001, Krisa Management LLC acquired 60% voting control of the Company. However, the court appointed control still remains with the Custodian until the Custodian files a petition with the District Court of Clark County, Nevada to relinquish custodianship and control of the Company.
On August 19, 2021, in a private transaction, Krisa Management LLC entered into a tentative agreement with a private individual to sell the Special 2021 Series A Preferred share. The sale is not yet closed and is dependent upon the Company successfully reinstating its DTC eligibility.
The address(es) of the issuer's principal executive office:
Medical Care Technologies Inc.
2245 Texas Drive, Suite 300
Sugar Land, TX 77498
The address(es) of the issuer's principal place of business:
Check box if principal executive office and principal place of business are the same address: ☒
Medical Care Technologies Inc.
2245 Texas Drive, Suite 300
Sugar Land, TX 77498
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 2 of 10 |
Has the issuer or any of its predecessors been in bankruptcy, receivership, or any similar proceeding in the past five years?
Yes: ☒ | No: ☐ |
If this issuer or any of its predecessors have been the subject of such proceedings, please provide additional details in the space below:
On May 28, 2021, the District Court of Clark County, Nevada, case number A21-834558-C, entered an Order Granting Application for Appointment (the "Order") of SSM Monopoly Corporation as Custodian of the Company. Pursuant to the Order, SSM Monopoly Corporation (the "Custodian") has the authority to take any actions on behalf of the Company, that are reasonable, prudent or for the benefit of the Company, including, but not limited to, issuing shares of stock and issuing new classes of stock, as well as entering into contracts on behalf of the Company. In addition, the Custodian, pursuant to the Order, is required to meet the requirements under the Nevada charter.
2) | Security Information | ||
Trading symbol: | MDCE | ||
Exact title and class of securities outstanding: | Common Stock | ||
CUSIP: | 584507305 | ||
Par or stated value: | 0.00001 | ||
Total shares authorized: | 7,979,999,990 | as of date: 09/30/2021 | |
Total shares outstanding: | 2,959,575,220 | as of date: 09/30/2021 | |
Number of shares in the Public Float2: | 959,574,825 | as of date: 09/30/2021 | |
Total number of shareholders of record: | 129 | as of date: 09/30/2021 | |
Trading symbol: | N/A | ||
Exact title and class of securities outstanding: | Special 2021 Series A Preferred Stock | ||
CUSIP: | N/A | ||
Par or stated value: | 0.00001 | ||
Total shares authorized: | 1 | as of date: 09/30/2021 | |
Total shares outstanding: | 1 | as of date: 09/30/2021 | |
Trading symbol: | N/A | ||
Exact title and class of securities outstanding: | Series A Preferred Stock | ||
CUSIP: | N/A | ||
Par or stated value: | 0.00001 | ||
Total shares authorized: | 10 | as of date: 09/30/2021 | |
Total shares outstanding: | 1 | as of date: 09/30/2021 | |
Trading symbol: | N/A | ||
Exact title and class of securities outstanding: | Series B Preferred Stock | ||
CUSIP: | N/A | ||
Par or stated value: | 0.00001 | ||
Total shares authorized: | 10,000,000 | as of date: 09/30/2021 | |
Total shares outstanding: | 129,800 | as of date: 09/30/2021 |
All additional class(es) of publicly traded securities (if any):
2 "Public Float" shall mean the total number of unrestricted shares not held directly or indirectly by an officer, director, any person who is the beneficial owner of more than 10 percent of the total shares outstanding (a "control person"), or any affiliates thereof, or any immediate family members of officers, directors and control persons.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 3 of 10 |
Transfer Agent | ||
Name: | Manhattan Transfer Registrar Co. | |
Phone: | 631-928-7655 | |
Email: | dcarlo@mtrco.com | |
Address: 38B Sheep Pasture Road, Port Jefferson, NY 11777 | ||
Is the Transfer Agent registered under the Exchange Act?3 Yes: ☒ | No: ☐ |
- Issuance History
The goal of this section is to provide disclosure with respect to each event that resulted in any direct changes to the total shares outstanding of any class of the issuer's securities in the past two completed fiscal years and any subsequent interim period.
Disclosure under this item shall include, in chronological order, all offerings and issuances of securities, including debt convertible into equity securities, whether private or public, and all shares, or any other securities or options to acquire such securities, issued for services. Using the tabular format below, please describe these events.
A. Changes to the Number of Outstanding Shares
Check this box to indicate there were no changes to the number of outstanding shares within the past two completed fiscal years and any subsequent periods: ☐
Shares Outstanding as of Second Most Recent | |||||||||||||||||||||||||||||||
Fiscal Year End: | Opening Balance | *Right-click the rows below and select "Insert" to add rows as needed. | |||||||||||||||||||||||||||||
Date 12/31/2018 | Common: 2,959,575,220 | ||||||||||||||||||||||||||||||
Preferred: | 129,801 | ||||||||||||||||||||||||||||||
Date of | Transaction | Number of | Class of | Value of | Were the | Individual/ Entity | Reason for share | Restricted or | Exemption | ||||||||||||||||||||||
Transaction | type (e.g. new | Shares | Securities | shares | shares | Shares were | issuance (e.g. for | Unrestricted | or | ||||||||||||||||||||||
issuance, | Issued (or | issued | issued at | issued to | cash or debt | as of this | Registration | ||||||||||||||||||||||||
cancellation, | cancelled) | ($/per | a discount | (entities must | conversion) | filing. | Type. | ||||||||||||||||||||||||
shares | share) at | to market | have individual | -OR- | |||||||||||||||||||||||||||
returned to | Issuance | price at | with voting / | Nature of | |||||||||||||||||||||||||||
treasury) | the time | investment | Services | ||||||||||||||||||||||||||||
of | control | Provided | |||||||||||||||||||||||||||||
issuance? | disclosed). | ||||||||||||||||||||||||||||||
(Yes/No) | |||||||||||||||||||||||||||||||
06/03/2021 | New | 1 | Special | 20,000 | N/A | SSM | Custodian | Restricted | Exempt | ||||||||||||||||||||||
Issuance | 2021 | Monopoly | Services | ||||||||||||||||||||||||||||
Series A | Corporation | ||||||||||||||||||||||||||||||
See (*) | See (*) | Preferred | See (*) | See (*) | (controlled by | See (*) Below | See (*) | See (*) | |||||||||||||||||||||||
Below | Below | Below | Below | Kareem | Below | Below | |||||||||||||||||||||||||
Mansour) | |||||||||||||||||||||||||||||||
3 To be included in the Pink Current Information tier, the transfer agent must be registered under the Exchange Act.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 4 of 10 |
Shares Outstanding on Date of This Report:
Ending Balance
Date 09/30/2021Common: 2,959,575,220
Preferred: 129,802
*Note: On June 14, 2021, in a private transaction, the custodian entered into a Securities Purchase Agreement with Krisa Management LLC, a Texas limited liability company controlled by Carey Cooley, to sell the Special 2021 Series A Preferred Stock for $20,000 to be paid in cash or any marketable security held by the borrower.
B. Debt Securities, Including Promissory and Convertible Notes
Use the chart and additional space below to list and describe all outstanding promissory notes, convertible notes, convertible debentures, or any other debt instruments that may be converted into a class of the issuer's equity securities.
Check this box if there are no outstanding promissory, convertible notes or debt arrangements: ☒
Date of | Outstanding | Principal | Interest | Maturity | Conversion Terms (e.g. | Name of Noteholder | Reason for | ||||||||||||||||
Note | Balance ($) | Amount | Accrued | Date | pricing mechanism for | (entities must have | Issuance (e.g. | ||||||||||||||||
Issuance | at | ($) | determining conversion of | individual with voting | Loan, Services, | ||||||||||||||||||
Issuance | instrument to shares) | / investment control | etc.) | ||||||||||||||||||||
($) | disclosed). | ||||||||||||||||||||||
Use the space below to provide any additional details, including footnotes to the table above:
N/A
- Financial Statements
A. The following financial statements were prepared in accordance with:
☒ U.S. GAAP ☐ IFRS
- The financial statements for this reporting period were prepared by (name of individual)4:
Name: | Carey W. Cooley |
Title: | President, CEO |
Relationship to Issuer: | Sole Officer, Director |
Provide the financial statements described below for the most recent fiscal year or quarter. For the initial disclosure statement (qualifying for Pink Current Information for the first time) please provide reports for the two previous fiscal years and any subsequent interim periods.
4 The financial statements requested pursuant to this item must be prepared in accordance with US GAAP or IFRS by persons with sufficient financial skills.
OTC Markets Group Inc. | |
OTC Pink Basic Disclosure Guidelines (v3.1 June 24, 2021) | Page 5 of 10 |
This is an excerpt of the original content. To continue reading it, access the original document here.
Attachments
- Original document
- Permalink
Disclaimer
Medical Care Technologies Inc. published this content on 10 November 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 10 November 2021 20:08:20 UTC.